The decisions made at the Greater Manchester Medicines Management Group (GMMMG) April 2024 meeting have now been reviewed by GM Executive and can be found at https://gmmmg.nhs.uk/meetings/decision-summaries/. This includes the recommendations made by GMMMG in April 2024 and NICE Technology appraisals published in December 2023.
The following decisions were approved and can be found at:
- Updates to formulary and RAG list – https://gmmmg.nhs.uk/joint-formulary/gmmmg-formulary-chapters/ and https://gmmmg.nhs.uk/rag-category/adult/. Full details are available in the formulary change log and in the decision summaries linked above.
- Preferred liquid melatonin preparations
- Budesonide 4 mg MR capsules for primary IgA nephropathy added as RED
- Empagliflozin for CKD added as GREEN
- Shared care protocol – melatonin for children and adolescents updated to include preferred liquid preparations https://gmmmg.nhs.uk/shared-care/gmmmg-approved-shared-care-protocols/
Colleagues are asked disseminate for implementation within your organisations.
All approved CRG and GMMMG meeting minutes can be found at: https://gmmmg.nhs.uk/meetings/clinical-reference-group/ and https://gmmmg.nhs.uk/meetings/gmmmg-meetings/.